Cypress Asset Management Inc Gsk PLC Transaction History

Cypress Asset Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$36.18 - $40.15 $220,698 - $244,915	-6,100 Closed	0 $0
Q4 2017 Jan 31, 2018	SELL	$35.34 - $41.9 $266,463 - $315,926	-7,540 Reduced 55.28%	6,100 $216,000
Q3 2017 Nov 08, 2017	BUY	$39.44 - $41.55 $537,961 - $566,742	13,640	13,640 $554,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.5B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Cypress Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cypress Asset Management Inc with notifications on news.